March/April 2011
Issue
Features
PFO in Cryptogenic Stroke Patients
The lead investigator from the REDUCE trial discusses his perspective on how these patients should be approached.
A Q&A with Scott Kasner, MD
Neurotoxin Therapy: A Closer Look at the Four Options
The field of neurotoxins has grown recently, but how do the agents compare? Here’s a closer look at the therapies available on the US market.
By Stephen Gollomp, MD
Viewpoints: Migraine: From Maimonides to Weisel
Ancient scholars and contemporary authors can provide insights on the experiences of patients with migraine and our treatment of them.
By Randolph W. Evans, MD
Departments
In The News
Editor’s Message
By Paul Winnington, Editorial Director
Diagnostic Q&A: Optical Coherence Tomography and Multiple Sclerosis
New findings suggest a novel in-office imaging technique can help identify MS patients who are likely to have increased disease severity. An investigator explains.
A Q&A with Shiv Saidha, MBBCh, MRCPI
Expert Opinion: Ultrasonographic Evaluation of Entrapment Neuropathies in the Upper Limb
Painless and low-cost, neuromuscular ultrasound can be an important adjuvant to clinical and electrodiagnostic findings in the evaluation of peripheral neuropathies.
By John W. Norbury, MD, Michael S. Cartwright, MD, Francis O. Walker, MD, Carolina Gutierrez MD, Daniel P. Moore MD, and Steven Mandel MD
Top 5 Articles From April 2011
Neurotoxin Therapy: A Closer Look at the Four Options
The field of neurotoxins has grown recently, but how do the agents compare? Here’s a closer look at the therapies available on the US market.
By Stephen Gollomp, MD
Diagnostic Q&A: Optical Coherence Tomography and Multiple Sclerosis
New findings suggest a novel in-office imaging technique can help identify MS patients who are likely to have increased disease severity. An investigator explains.
By A Q&A with Shiv Saidha, MBBCh, MRCPI
Expert Opinion: Ultrasonographic Evaluation of Entrapment Neuropathies in the Upper Limb
Painless and low-cost, neuromuscular ultrasound can be an important adjuvant to clinical and electrodiagnostic findings in the evaluation of peripheral neuropathies.
By John W. Norbury, MD, Michael S. Cartwright, MD, Francis O. Walker, MD, Carolina Gutierrez MD, Daniel P. Moore MD, and Steven Mandel MD
PFO in Cryptogenic Stroke Patients
The lead investigator from the REDUCE trial discusses his perspective on how these patients should be approached.
By A Q&A with Scott Kasner, MD
Viewpoints: Migraine: From Maimonides to Weisel
Ancient scholars and contemporary authors can provide insights on the experiences of patients with migraine and our treatment of them.
